D.E. Shaw & Co’s Contineum Therapeutics CTNM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$152K Buy
+11,357
New +$169K ﹤0.01% 4672

Other funds holding CTNM

D.E. Shaw & Co's CTNM Position: Q3 2026 in Review

D.E. Shaw & Co opened a new position in Contineum Therapeutics (CTNM) in Q3 2026: 11,357 shares worth $152K. The stake represents ﹤0.01% of the portfolio and ranks #4672 among its holdings.

118 funds tracked by Wall St. Rank hold CTNM as of Q3 2026.

  • D.E. Shaw & Co held 11,357 shares of Contineum Therapeutics worth $152K as of Q3 2026.
  • Contineum Therapeutics was a new D.E. Shaw & Co position in Q3 2026.
  • Contineum Therapeutics made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q3 2026, its #4672 holding.
  • 118 funds tracked by Wall St. Rank held Contineum Therapeutics as of Q3 2026.

Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.